Fortive Reports Q3 2026 Results and Raises Full-Year Adjusted EPS Guidance

Overview

On October 28, 2026, Fortive Corporation filed a Current Report on Form 8-K under Item 2.02 (Results of Operations and Financial Condition), furnishing its third-quarter financial results for the period ended October 2, 2026.

Key Financial Highlights

• Revenue Growth: Total revenue reached $1.11 billion, an increase of 7.8% year-over-year on a reported basis and 7.2% on a core basis.
• Earnings:
  • GAAP Net Earnings: $173 million (+47.4% YoY), with a GAAP net earnings margin of 15.6%.
  • Adjusted EBITDA: $339 million (+9.5% YoY), reflecting an adjusted EBITDA margin of 30.6%.
  • Diluted EPS: GAAP diluted EPS was $0.57 (+62.9% YoY); adjusted diluted EPS was $0.77 (+13.2% YoY).
• Cash Flow:
  • GAAP operating cash flow stood at $313 million (TTM: $1,177 million).
  • Free cash flow was $284 million (TTM: $1,062 million).

Segment Performance (Continuing Operations)

• Intelligent Operating Solutions:
  • Revenue: $767 million (+9.8% reported / +9.1% core YoY).
  • Adjusted EBITDA: $275 million (+13.6% YoY) with a 35.8% margin.
• Advanced Healthcare Solutions:
  • Revenue: $340 million (+3.7% reported / +3.1% core YoY).
  • Adjusted EBITDA: $88 million (-4.8% YoY) with a 25.8% margin.

Capital Allocation & Share Repurchases

During Q3 2026, Fortive deployed approximately $300 million to repurchase roughly 5 million shares (~2% of diluted shares outstanding). Since the launch of "new Fortive," total buybacks have reached approximately $2.3 billion (~43 million shares, representing ~13% of shares outstanding).

Guidance Update

Management raised full-year 2026 adjusted diluted EPS guidance to a range of $3.10 to $3.14, representing approximately 15% year-over-year growth at the midpoint.